Calcium supplements linked to reduced renal cell carcinoma risk in postmenopausal women.
This article was originally published in The Tan Sheet
Executive Summary
CALCIUM SUPPLEMENT USE LINKED TO REDUCED RENAL CELL CARCINOMA RISK in a study involving 35,192 postmenopausal women published in the January issue of Epidemiology. "Total dietary calcium (relative risks=.48 and .66 for the 2nd and 3rd tertiles) and calcium supplement use (RR=.52) were inversely associated with risk of renal cell carcinoma," Ronald Prineas et al. concluded. Prineas is with the University of Miami; the other researchers are with the University of Minnesota and the Fred Hutchinson Cancer Research Center in Seattle. The study was funded in part by a grant from the National Cancer Institute.